Amanta Healthcare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,877	2,747	2,803	2,591	2,254
Other Revenue	33.71	-	-	-	-
Revenue	2,910	2,747	2,803	2,591	2,254
Revenue Growth (YoY)	5.95%	-2.01%	8.19%	14.94%	31.61%
Cost of Revenue	966.46	948.23	1,051	1,018	767.95
Gross Profit	1,944	1,799	1,752	1,574	1,486
Selling, General & Admin	429.61	363.88	326.12	326.62	292.41
Other Operating Expenses	882.12	838.28	851.33	715.02	657.78
Operating Expenses	1,499	1,386	1,375	1,225	1,123
Operating Income	444.99	412.7	377.6	348.57	363.49
Interest Expense	-207.46	-269.66	-323.97	-343.85	-430.58
Interest & Investment Income	-	3.09	3.29	8.05	3.35
Currency Exchange Gain (Loss)	-	0.68	-	18.98	3.17
Other Non Operating Income (Expenses)	-	-7.97	-5.87	-8.52	-8.36
EBT Excluding Unusual Items	237.54	138.84	51.05	23.23	-68.93
Gain (Loss) on Sale of Investments	-	5.01	2.48	1.33	1.31
Gain (Loss) on Sale of Assets	-	-	-	-4.64	-
Other Unusual Items	-26.29	1.85	-	5.34	685.23
Pretax Income	211.25	147.07	53.89	26.9	617.87
Income Tax Expense	62.5	42.06	17.56	48.01	79.06
Net Income	148.75	105.01	36.33	-21.11	538.82
Net Income to Common	148.75	105.01	36.33	-21.11	538.82
Net Income Growth	41.66%	189.02%	-	-	-
Shares Outstanding (Basic)	34	28	27	27	27
Shares Outstanding (Diluted)	34	28	27	27	27
Shares Change (YoY)	21.52%	5.37%	-0.00%	-	0.00%
EPS (Basic)	4.33	3.71	1.35	-0.79	20.08
EPS (Diluted)	4.33	3.71	1.35	-0.79	20.08
EPS Growth	16.71%	174.81%	-	-	-
Free Cash Flow	-317.4	258.46	446.62	362.9	535.62
Free Cash Flow Per Share	-9.24	9.14	16.65	13.53	19.96
Gross Margin	66.79%	65.48%	62.51%	60.73%	65.94%
Operating Margin	15.29%	15.02%	13.47%	13.45%	16.12%
Profit Margin	5.11%	3.82%	1.30%	-0.81%	23.90%
Free Cash Flow Margin	-10.90%	9.41%	15.93%	14.00%	23.76%
EBITDA	632.29	578.47	548.72	513.77	527.72
EBITDA Margin	21.73%	21.06%	19.57%	19.83%	23.41%
D&A For EBITDA	187.3	165.77	171.12	165.2	164.24
EBIT	444.99	412.7	377.6	348.57	363.49
EBIT Margin	15.29%	15.02%	13.47%	13.45%	16.12%
Effective Tax Rate	29.58%	28.60%	32.58%	178.46%	12.80%
Revenue as Reported	2,910	2,760	2,816	2,627	2,263

Source: S&P Global Market Intelligence. Standard template. Financial Sources.